{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:59:31Z","timestamp":1777593571809,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T00:00:00Z","timestamp":1506988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T00:00:00Z","timestamp":1506988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA137488-22"],"award-info":[{"award-number":["R01 CA137488-22"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA199111-33"],"award-info":[{"award-number":["R01 CA199111-33"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007155","name":"Walter S. and Lucienne Driskill Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["Merit Review Grant"],"award-info":[{"award-number":["Merit Review Grant"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12987-017-0075-0","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T06:56:46Z","timestamp":1507100206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency"],"prefix":"10.1186","volume":"14","author":[{"given":"Edit","family":"D\u00f3sa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krisztina","family":"Heltai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Radovits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Kapocsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9la","family":"Merkely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongwei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy D.","family":"Doolittle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerda B.","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Urdang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6679-6203","authenticated-orcid":false,"given":"Edward A.","family":"Neuwelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,3]]},"reference":[{"key":"75_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3109\/03005369509076750","volume":"29","author":"HM Robinshaw","year":"1995","unstructured":"Robinshaw HM. Early intervention for hearing impairment: differences in the timing of communicative and linguistic development. Br J Audiol. 1995;29:315\u201334.","journal-title":"Br J Audiol"},{"key":"75_CR2","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1542\/peds.102.5.1161","volume":"102","author":"C Yoshinaga-Itano","year":"1998","unstructured":"Yoshinaga-Itano C, Sedey AL, Coulter DK, Mehl AL. Language of early- and later-identified children with hearing loss. Pediatrics. 1998;102:1161\u201371.","journal-title":"Pediatrics"},{"key":"75_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.heares.2006.09.015","volume":"226","author":"LP Rybak","year":"2007","unstructured":"Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res. 2007;226:157\u201367.","journal-title":"Hear Res"},{"key":"75_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF00165482","volume":"27","author":"R Assietti","year":"1996","unstructured":"Assietti R, Olson JJ. Intra-arterial cisplatin in malignant brain tumors: incidence and severity of otic toxicity. J Neurooncol. 1996;27:251\u20138.","journal-title":"J Neurooncol"},{"key":"75_CR5","first-page":"706","volume":"56","author":"EA Neuwelt","year":"1996","unstructured":"Neuwelt EA, Brummett RE, Remsen LG, Kroll RA, Pagel MA, McCormick CI, Guitjens S, Muldoon LL. In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity. Cancer Res. 1996;56:706\u20139.","journal-title":"Cancer Res"},{"key":"75_CR6","doi-asserted-by":"publisher","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","volume":"23","author":"KR Knight","year":"2005","unstructured":"Knight KR, Kraemer DF, Neuwelt EA. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol. 2005;23:8588\u201396.","journal-title":"J Clin Oncol"},{"key":"75_CR7","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1124\/jpet.105.087601","volume":"314","author":"DT Dickey","year":"2005","unstructured":"Dickey DT, Wu YJ, Muldoon LL, Neuwelt EA. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels. J Pharmacol Exp Ther. 2005;314:1052\u20138.","journal-title":"J Pharmacol Exp Ther"},{"key":"75_CR8","first-page":"309","volume":"6","author":"LL Muldoon","year":"2000","unstructured":"Muldoon LL, Pagel MA, Kroll RA, Brummett RE, Doolittle ND, Zuhowski EG, Egorin MJ, Neuwelt EA. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clin Cancer Res. 2000;6:309\u201315.","journal-title":"Clin Cancer Res"},{"key":"75_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.tox.2003.10.012","volume":"195","author":"M Naziroglu","year":"2004","unstructured":"Naziroglu M, Karaoglu A, Aksoy AO. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology. 2004;195:221\u201330.","journal-title":"Toxicology"},{"key":"75_CR10","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1200\/JCO.2003.05.139","volume":"21","author":"A Pace","year":"2003","unstructured":"Pace A, Savarese A, Picardo M, Maresca V, Pacetti U, Del Monte G, Biroccio A, Leonetti C, Jandolo B, Cognetti F, Bove L. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol. 2003;21:927\u201331.","journal-title":"J Clin Oncol"},{"key":"75_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1472-8206.2000.tb00440.x","volume":"14","author":"G Sener","year":"2000","unstructured":"Sener G, Satiroglu H, Kabasakal L, Arbak S, Oner S, Ercan F, Keyer-Uysa M. The protective effect of melatonin on cisplatin nephrotoxicity. Fundam Clin Pharmacol. 2000;14:553\u201360.","journal-title":"Fundam Clin Pharmacol"},{"key":"75_CR12","doi-asserted-by":"publisher","first-page":"F208","DOI":"10.1152\/ajprenal.00311.2002","volume":"285","author":"K Tsuruya","year":"2003","unstructured":"Tsuruya K, Tokumoto M, Ninomiya T, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Hirakata H, Iida M. Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways. Am J Physiol Renal Physiol. 2003;285:F208\u201318.","journal-title":"Am J Physiol Renal Physiol"},{"key":"75_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1124\/jpet.104.075119","volume":"312","author":"YJ Wu","year":"2005","unstructured":"Wu YJ, Muldoon LL, Neuwelt EA. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J Pharmacol Exp Ther. 2005;312:424\u201331.","journal-title":"J Pharmacol Exp Ther"},{"key":"75_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jvir.2007.11.003","volume":"19","author":"DA Stenstrom","year":"2008","unstructured":"Stenstrom DA, Muldoon LL, Armijo-Medina H, Watnick S, Doolittle ND, Kaufman JA, Peterson DR, Bubalo J, Neuwelt EA. N-Acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials. J Vasc Interv Radiol. 2008;19:309\u201318.","journal-title":"J Vasc Interv Radiol"},{"key":"75_CR15","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1080\/0886022X.2016.1207052","volume":"38","author":"S Chu","year":"2016","unstructured":"Chu S, Hu L, Wang X, Sun S, Zhang T, Sun Z, Shen L, Jin S, He B. Xuezhikang ameliorates contrast media-induced nephropathy in rats via suppression of oxidative stress, inflammatory responses and apoptosis. Ren Fail. 2016;38:1717\u201325.","journal-title":"Ren Fail"},{"key":"75_CR16","first-page":"479","volume":"7","author":"L Gao","year":"2016","unstructured":"Gao L, Wu WF, Dong L, Ren GL, Li HD, Yang Q, Li XF, Xu T, Li Z, Wu BM, et al. Protocatechuic aldehyde attenuates cisplatin-induced acute kidney injury by suppressing nox-mediated oxidative stress and renal inflammation. Front Pharmacol. 2016;7:479.","journal-title":"Front Pharmacol"},{"key":"75_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jphs.2016.03.006","volume":"131","author":"X He","year":"2016","unstructured":"He X, Li L, Tan H, Chen J, Zhou Y. Atorvastatin attenuates contrast-induced nephropathy by modulating inflammatory responses through the regulation of JNK\/p38\/Hsp27 expression. J Pharmacol Sci. 2016;131:18\u201327.","journal-title":"J Pharmacol Sci"},{"key":"75_CR18","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1523\/JNEUROSCI.3111-15.2016","volume":"36","author":"T Kaur","year":"2016","unstructured":"Kaur T, Borse V, Sheth S, Sheehan K, Ghosh S, Tupal S, Jajoo S, Mukherjea D, Rybak LP, Ramkumar V. Adenosine A1 receptor protects against cisplatin ototoxicity by suppressing the NOX3\/STAT1 inflammatory pathway in the cochlea. J Neurosci. 2016;36:3962\u201377.","journal-title":"J Neurosci"},{"key":"75_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ejphar.2015.12.042","volume":"772","author":"CZ Li","year":"2016","unstructured":"Li CZ, Jin HH, Sun HX, Zhang ZZ, Zheng JX, Li SH, Han SH. Eriodictyol attenuates cisplatin-induced kidney injury by inhibiting oxidative stress and inflammation. Eur J Pharmacol. 2016;772:124\u201330.","journal-title":"Eur J Pharmacol"},{"key":"75_CR20","doi-asserted-by":"publisher","first-page":"9050828","DOI":"10.1155\/2016\/9050828","volume":"2016","author":"D Onk","year":"2016","unstructured":"Onk D, Onk OA, Turkmen K, Erol HS, Ayazoglu TA, Keles ON, Halici M, Topal E. Melatonin attenuates contrast-induced nephropathy in diabetic rats: the role of interleukin-33 and oxidative stress. Mediators Inflamm. 2016;2016:9050828.","journal-title":"Mediators Inflamm"},{"key":"75_CR21","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1046\/j.1460-9568.2003.02966.x","volume":"18","author":"L Helboe","year":"2003","unstructured":"Helboe L, Egebjerg J, Moller M, Thomsen C. Distribution and pharmacology of alanine\u2013serine\u2013cysteine transporter 1 (asc-1) in rodent brain. Eur J Neurosci. 2003;18:2227\u201338.","journal-title":"Eur J Neurosci"},{"key":"75_CR22","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.bbi.2012.07.003","volume":"26","author":"MA Erickson","year":"2012","unstructured":"Erickson MA, Hansen K, Banks WA. Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood\u2013brain barrier: protection by the antioxidant N-acetylcysteine. Brain Behav Immun. 2012;26:1085\u201394.","journal-title":"Brain Behav Immun"},{"key":"75_CR23","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1046\/j.1471-4159.2003.01580.x","volume":"84","author":"SA Farr","year":"2003","unstructured":"Farr SA, Poon HF, Dogrukol-Ak D, Drake J, Banks WA, Eyerman E, Butterfield DA, Morley JE. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem. 2003;84:1173\u201383.","journal-title":"J Neurochem"},{"key":"75_CR24","first-page":"7868","volume":"61","author":"EA Neuwelt","year":"2001","unstructured":"Neuwelt EA, Pagel MA, Hasler BP, Deloughery TG, Muldoon LL. Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model. Cancer Res. 2001;61:7868\u201374.","journal-title":"Cancer Res"},{"key":"75_CR25","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.2215\/CJN.11161012","volume":"8","author":"SD Weisbord","year":"2013","unstructured":"Weisbord SD, Gallagher M, Kaufman J, Cass A, Parikh CR, Chertow GM, Shunk KA, McCullough PA, Fine MJ, Mor MK, et al. Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial. Clin J Am Soc Nephrol. 2013;8:1618\u201331.","journal-title":"Clin J Am Soc Nephrol"},{"key":"75_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1056\/NEJM200007203430304","volume":"343","author":"M Tepel","year":"2000","unstructured":"Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180\u20134.","journal-title":"N Engl J Med"},{"key":"75_CR27","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00280-011-1656-2","volume":"68","author":"CE Berglin","year":"2011","unstructured":"Berglin CE, Pierre PV, Bramer T, Edsman K, Ehrsson H, Eksborg S, Laurell G. Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model. Cancer Chemother Pharmacol. 2011;68:1547\u201356.","journal-title":"Cancer Chemother Pharmacol"},{"key":"75_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00280-007-0597-2","volume":"62","author":"DT Dickey","year":"2008","unstructured":"Dickey DT, Muldoon LL, Doolittle ND, Peterson DR, Kraemer DF, Neuwelt EA. Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models. Cancer Chemother Pharmacol. 2008;62:235\u201341.","journal-title":"Cancer Chemother Pharmacol"},{"key":"75_CR29","doi-asserted-by":"publisher","first-page":"BR179","DOI":"10.12659\/MSM.881894","volume":"17","author":"G Lorito","year":"2011","unstructured":"Lorito G, Hatzopoulos S, Laurell G, Campbell KCM, Petruccelli J, Giordano P, Kochanek K, Sliwa L, Martini A, Skarzynski H. Dose-dependent protection on cisplatin-induced ototoxicity\u2014an electrophysiological study on the effect of three antioxidants in the Sprague-Dawley rat animal model. Med Sci Monit. 2011;17:BR179\u201386.","journal-title":"Med Sci Monit"},{"key":"75_CR30","doi-asserted-by":"publisher","first-page":"E87","DOI":"10.1002\/lary.24360","volume":"124","author":"J Yoo","year":"2014","unstructured":"Yoo J, Hamilton SJ, Angel D, Fung K, Franklin J, Parnes LS, Lewis D, Venkatesan V, Winquist E. Cisplatin otoprotection using transtympanic l-N-acetylcysteine: a pilot randomized study in head and neck cancer patients. Laryngoscope. 2014;124:E87\u201394.","journal-title":"Laryngoscope"},{"key":"75_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.heares.2004.02.007","volume":"193","author":"D Thomas Dickey","year":"2004","unstructured":"Thomas Dickey D, Muldoon LL, Kraemer DF, Neuwelt EA. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model. Hear Res. 2004;193:25\u201330.","journal-title":"Hear Res"},{"key":"75_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247\u201354.","journal-title":"Ann Intern Med"},{"key":"75_CR33","unstructured":"Heard K, Dart R. Acetaminophen (paracetamol) poisoning in adults: Treatment. 8\/30\/2016 edition. \n                    http:\/\/www.uptodate.com\n                    \n                  : Wolters Kluwer; 2016."},{"key":"75_CR34","unstructured":"Common terminology criteria for adverse events, version 3.0, DCTD, NCI, NIH, DHHS. [\n                    http:\/\/ctep.cancer.gov\n                    \n                  ]."},{"key":"75_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/15563650802665587","volume":"47","author":"EA Sandilands","year":"2009","unstructured":"Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol (Phila). 2009;47:81\u20138.","journal-title":"Clin Toxicol (Phila)"},{"key":"75_CR36","doi-asserted-by":"publisher","first-page":"S676","DOI":"10.1161\/CIRCULATIONAHA.110.970913","volume":"122","author":"AH Travers","year":"2010","unstructured":"Travers AH, Rea TD, Bobrow BJ, Edelson DP, Berg RA, Sayre MR, Berg MD, Chameides L, O\u2019Connor RE, Swor RA. Part 4: CPR overview: 2010 American Heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010;122:S676\u201384.","journal-title":"Circulation"},{"key":"75_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/WOX.0b013e318211496c","volume":"4","author":"FE Simons","year":"2011","unstructured":"Simons FE, Ardusso LR, Bilo MB, El-Gamal YM, Ledford DK, Ring J, Sanchez-Borges M, Senna GE, Sheikh A, Thong BY. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011;4:13\u201337.","journal-title":"World Allergy Organ J"},{"key":"75_CR38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/01.ASN.0000107562.68920.92","volume":"15","author":"S Fishbane","year":"2004","unstructured":"Fishbane S, Durham JH, Marzo K, Rudnick M. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol. 2004;15:251\u201360.","journal-title":"J Am Soc Nephrol"},{"key":"75_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3109\/00365519409085464","volume":"54","author":"B Hultberg","year":"1994","unstructured":"Hultberg B, Andersson A, Masson P, Larson M, Tunek A. Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine. Scand J Clin Lab Invest. 1994;54:417\u201322.","journal-title":"Scand J Clin Lab Invest"},{"key":"75_CR40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ehj.2003.11.016","volume":"25","author":"C Briguori","year":"2004","unstructured":"Briguori C, Colombo A, Violante A, Balestrieri P, Manganelli F, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, et al. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J. 2004;25:206\u201311.","journal-title":"Eur Heart J"},{"key":"75_CR41","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1056\/NEJMoa054209","volume":"354","author":"G Marenzi","year":"2006","unstructured":"Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, Montorsi P, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006;354:2773\u201382.","journal-title":"N Engl J Med"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-017-0075-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12987-017-0075-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-017-0075-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T09:49:14Z","timestamp":1589536154000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-017-0075-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,3]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["75"],"URL":"https:\/\/doi.org\/10.1186\/s12987-017-0075-0","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,3]]},"assertion":[{"value":"12 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"26"}}